Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
6MP and Methotrexate in BRCA-Defective Tumours
NCT01432145Phase 2Completed
- Sponsor
- University of Oxford
- Start
- May 2011
- Primary completion
- Dec 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of mercaptopurine in breast cancer, ovarian cancer, sponsored by University of Oxford. Started May 2011; status: completed.
02
Drugs
mercaptopurine
03
Conditions
breast cancerovarian cancer
Beyond the preview
Go deeper on NCT01432145.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01432145.